532296:BOM
Glenmark Pharmaceuticals Ltd
₹2,224.00
arrow_downward
-1.17%(-26.30) 1D
Oct 16, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532296...
Open
₹2,249.80
High
₹2,264.00
Low
₹2,224.00
Mkt. cap
628.43B
Avg. vol.
17.97K
Volume
12.94K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
34.92
52-wk high
₹2,536.85
52-wk low
₹1,794.00
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
Open
₹2,249.80
High
₹2,264.00
Low
₹2,224.00
Mkt. cap
628.43B
Avg. vol.
17.97K
Volume
12.94K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
34.92
52-wk high
₹2,536.85
52-wk low
₹1,794.00
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
News stories
From web sources and news partners
BigGo Finance
·
1 hour ago
Nasdaq Plunges Over 2% in a Day as Oil Prices Top $100
ETF Database
·
2 hours ago
S&P 500 Snapshot: Stocks Slide Nearly 2% for the Week
ChartMill
·
6 hours ago
Dow Jones Losers: GOOGL, CRM, MSFT, AMZN, CSCO in Today's US Session
marketscreener.com
·
4 hours ago
Nasdaq Falls to End Four-Week Winning Streak Amid Tech Sell-Off
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd